Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AMO Adds Glaucoma Device, Fills Cataract Line With $450 Mil. Pfizer Eye Unit

This article was originally published in The Gray Sheet

Executive Summary

Advanced Medical Optics' purchase of Pfizer's surgical ophthalmology business bolsters its cataract surgery portfolio by adding viscoelastics and expanded intraocular lens (IOL) offerings

You may also be interested in...



Boston University-Raised Solx Will Leave The Nest With DeepLight Launch

Solx plans to formally begin commercial operations when it launches the DeepLight glaucoma treatment system at the International Glaucoma Symposium in Cape Town, South Africa, March 30-April 2

Boston University-Raised Solx Will Leave The Nest With DeepLight Launch

Solx plans to formally begin commercial operations when it launches the DeepLight glaucoma treatment system at the International Glaucoma Symposium in Cape Town, South Africa, March 30-April 2

AMO To Surround Eye Surgeons With Refractive Offerings After Visx Purchase

Advanced Medical Optics' acquisition of pure-play LASIK manufacturer Visx will enable the combined entity to more effectively market laser eye surgery to physicians performing both refractive and cataract procedures

Related Content

UsernamePublicRestriction

Register

LL016481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel